Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1Phase 1/2 1

Status

Recruiting 3Completed 3Suspended 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3

Conditions

Prostatic Neoplasms 18Neoplasms 18Breast Neoplasms 16Colorectal Neoplasms 12Carcinoma, Non-Small-Cell Lung 11Lung Neoplasms 10Urinary Bladder Neoplasms 6Squamous Cell Carcinoma of Head and Neck 6Hematopoietic and Lymphatic System Neoplasm 6Hematologic Neoplasms 6Ovarian Neoplasms 5Neoplasm Metastasis 5Triple Negative Breast Neoplasms 4Leukemia, Myeloid, Acute 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Pancreatic Neoplasms 3Multiple Myeloma 3Mouth Neoplasms 3Hematopoietic and Lymphoid System Neoplasm 3Head and Neck Neoplasms 3Fallopian Tube Neoplasms 3Carcinoma, Renal Cell 3Sarcoma 2Radiodermatitis 2Peritoneal Neoplasms 2Pathologic Complete Response 2Parotid Neoplasms 2Motor Activity 2Melanoma 2Malignant Solid Neoplasm 2

Interventions

Nivolumab 28pembrolizumab 24cabozantinib 22Ipilimumab 19Specimen Handling 14Magnetic Resonance Spectroscopy 13Axitinib 12lenvatinib 10Radiosurgery 9belzutifan 8CTLA-4 Antigen 7Biopsy 7atezolizumab 6cemiplimab 5Radiotherapy 5Bevacizumab 5toripalimab 4Everolimus 4Blood Specimen Collection 4avelumab 3aldesleukin 3X-Rays 3Sunitinib 3Standard of Care 3Paclitaxel 3zimberelimab 2trastuzumab deruxtecan 2tivozanib 2spartalizumab 2pazopanib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × Carcinoma, Renal Cell × Standard of Care × Clear all
NCT05519878 2025-12-24

Light Therapy and Occupational Therapy Fatigue Management-Based Intervention for Patients With Genitourinary Cancers

City of Hope Medical Center

Phase NA Recruiting
224 enrolled
Genitourinary

Urinary Bladder Neoplasms, Carcinoma, Renal Cell, Prostatic Neoplasms

NCT07053462 2025-07-08

CRISPR-Edited HLA Donor Kidney Transplant to Reduce Rejection Risk

AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC

Phase 1/2 Recruiting
90 enrolled
Genitourinary

Carcinoma, Renal Cell, Kidney Failure, Chronic, Renal Insufficiency

NCT06903312 2025-07-03

ITALIC-RCC

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Phase 4 Recruiting
409 enrolled
Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡